Table of Content

1 Influenza Vaccine Market Introduction and Overview
1.1 Influenza Vaccine Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Influenza Vaccine Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Influenza Vaccine Revenue and Market Share by Type
3 Global Influenza Vaccine Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Influenza Vaccine Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Influenza Vaccine Market Size (2019-2024)
4.2 Influenza Vaccine Growth Trends Analysis by Regions
4.2.1 Influenza Vaccine Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Influenza Vaccine Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Influenza Vaccine Market Size (2019-2024)
4.2.4 Europe Influenza Vaccine Market Size (2019-2024)
4.2.5 Asia-Pacific Influenza Vaccine Market Size (2019-2024)
4.2.6 Latin America Influenza Vaccine Market Size (2019-2024)
4.2.7 Middle East & Africa Influenza Vaccine Market Size (2019-2024)
5 North America
5.1 North America Influenza Vaccine Revenue by Countries
5.1.1 North America Influenza Vaccine Revenue by Countries (2019-2024)
5.2 North America Influenza Vaccine Revenue by Types
5.3 North America Influenza Vaccine Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Influenza Vaccine Revenue by Countries
6.1.1 Asia Pacific Influenza Vaccine Revenue by Countries (2019-2024)
6.2 Asia Pacific Influenza Vaccine Revenue by Types
6.3 Asia Pacific Influenza Vaccine Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Influenza Vaccine Revenue by Countries
7.1.1 Europe Influenza Vaccine Revenue by Countries (2019-2024)
7.2 Europe Influenza Vaccine Revenue by Types
7.3 Europe Influenza Vaccine Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Influenza Vaccine Revenue by Countries
8.1.1 Latin America Influenza Vaccine Revenue by Countries (2019-2024)
8.2 Latin America Influenza Vaccine Revenue by Types
8.3 Latin America Influenza Vaccine Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Influenza Vaccine Revenue by Countries
9.1.1 Middle East & Africa Influenza Vaccine Revenue by Countries (2019-2024)
9.2 Middle East & Africa Influenza Vaccine Revenue by Types
9.3 Middle East & Africa Influenza Vaccine Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Influenza Vaccine Market Competition, by Players
10.1 Global Influenza Vaccine Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Influenza Vaccine Players Market Share in 2023
10.2.2 Top 6 Influenza Vaccine Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Influenza Vaccine Players Head Office, Business Provided
10.4 Influenza Vaccine Mergers & Acquisitions
10.5 Influenza Vaccine New Entrants and Expansion Plans
11 Players Profiles11.1 Hualan Bio
11.1.1 Hualan Bio Company Profile
11.1.2 Influenza Vaccine Product Overview
11.1.3 Hualan Bio Influenza Vaccine Market Performance (2019-2024)
11.1.4 Hualan Bio Business Overview
11.1.5 Recent Developments and Plans
11.2 SANOFI
11.2.1 SANOFI Company Profile
11.2.2 Influenza Vaccine Product Overview
11.2.3 SANOFI Influenza Vaccine Market Performance (2019-2024)
11.2.4 SANOFI Business Overview
11.2.5 Recent Developments and Plans
11.3 CCBIO
11.3.1 CCBIO Company Profile
11.3.2 Influenza Vaccine Product Overview
11.3.3 CCBIO Influenza Vaccine Market Performance (2019-2024)
11.3.4 CCBIO Business Overview
11.3.5 Recent Developments and Plans
11.4 Changsheng Biological
11.4.1 Changsheng Biological Company Profile
11.4.2 Influenza Vaccine Product Overview
11.4.3 Changsheng Biological Influenza Vaccine Market Performance (2019-2024)
11.4.4 Changsheng Biological Business Overview
11.4.5 Recent Developments and Plans
11.5 SINOVAC
11.5.1 SINOVAC Company Profile
11.5.2 Influenza Vaccine Product Overview
11.5.3 SINOVAC Influenza Vaccine Market Performance (2019-2024)
11.5.4 SINOVAC Business Overview
11.5.5 Recent Developments and Plans
11.6 SIOBP
11.6.1 SIOBP Company Profile
11.6.2 Influenza Vaccine Product Overview
11.6.3 SIOBP Influenza Vaccine Market Performance (2019-2024)
11.6.4 SIOBP Business Overview
11.6.5 Recent Developments and Plans
11.7 Aleph Biomedical
11.7.1 Aleph Biomedical Company Profile
11.7.2 Influenza Vaccine Product Overview
11.7.3 Aleph Biomedical Influenza Vaccine Market Performance (2019-2024)
11.7.4 Aleph Biomedical Business Overview
11.7.5 Recent Developments and Plans
11.8 Adimmune
11.8.1 Adimmune Company Profile
11.8.2 Influenza Vaccine Product Overview
11.8.3 Adimmune Influenza Vaccine Market Performance (2019-2024)
11.8.4 Adimmune Business Overview
11.8.5 Recent Developments and Plans
11.9 ZYAK
11.9.1 ZYAK Company Profile
11.9.2 Influenza Vaccine Product Overview
11.9.3 ZYAK Influenza Vaccine Market Performance (2019-2024)
11.9.4 ZYAK Business Overview
11.9.5 Recent Developments and Plans
11.10 GSK
11.10.1 GSK Company Profile
11.10.2 Influenza Vaccine Product Overview
11.10.3 GSK Influenza Vaccine Market Performance (2019-2024)
11.10.4 GSK Business Overview
11.10.5 Recent Developments and Plans
11.11 Aimei Hissen
11.11.1 Aimei Hissen Company Profile
11.11.2 Influenza Vaccine Product Overview
11.11.3 Aimei Hissen Influenza Vaccine Market Performance (2019-2024)
11.11.4 Aimei Hissen Business Overview
11.11.5 Recent Developments and Plans
11.12 Tianyuan Bio-pharma
11.12.1 Tianyuan Bio-pharma Company Profile
11.12.2 Influenza Vaccine Product Overview
11.12.3 Tianyuan Bio-pharma Influenza Vaccine Market Performance (2019-2024)
11.12.4 Tianyuan Bio-pharma Business Overview
11.12.5 Recent Developments and Plans
11.13 Simcere Vaxtec
11.13.1 Simcere Vaxtec Company Profile
11.13.2 Influenza Vaccine Product Overview
11.13.3 Simcere Vaxtec Influenza Vaccine Market Performance (2019-2024)
11.13.4 Simcere Vaxtec Business Overview
11.13.5 Recent Developments and Plans
11.14 Tiantan Biological
11.14.1 Tiantan Biological Company Profile
11.14.2 Influenza Vaccine Product Overview
11.14.3 Tiantan Biological Influenza Vaccine Market Performance (2019-2024)
11.14.4 Tiantan Biological Business Overview
11.14.5 Recent Developments and Plans
12 Global Influenza Vaccine Forecast Market Analysis by Type
12.1 Global Influenza Vaccine Revenue Market Forecast by Type (2024-2030)
13 Global Influenza Vaccine Forecast Market Analysis by Application
13.1 Influenza Vaccine Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Influenza Vaccine Forecast Market Size (2024-2030)
14.2 Influenza Vaccine Growth Trends Forecast Analysis by Regions
14.2.1 Influenza Vaccine Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Influenza Vaccine Forecast Market Size (2024-2030)
14.2.3 Europe Influenza Vaccine Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Influenza Vaccine Forecast Market Size (2024-2030)
14.2.5 Latin America Influenza Vaccine Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Influenza Vaccine Forecast Market Size (2024-2030)
15 Influenza Vaccine Industry Dynamic Analysis
15.1 Influenza Vaccine Market Trends Analysis
15.2 Influenza Vaccine Market Drivers Analysis
15.3 Influenza Vaccine Market Challenges Analysis
15.4 Influenza Vaccine Market Restraints Analysis